US EditionTrump signs executive order slashing prescription drug costs by up to 80%
- President Donald Trump signed an executive order on Monday, May 12, 2025, at the White House to reduce prescription drug costs under Medicare Part B in the United States.
- This action revives a previously blocked policy from Trump's 2020 term designed to tie Medicare drug prices to the lowest prices paid by other economically advanced countries.
- The order focuses on certain medications administered in doctors’ offices, such as cancer infusions and injectables, while common pharmacy drugs likely remain unaffected by the policy.
- Trump announced plans to implement a Most Favored Nation policy that would require the United States to match the lowest price paid by any country worldwide for certain medications. He claimed this approach could save taxpayers potentially trillions of dollars, although some experts view that figure as an overstatement.
- The proposal faces strong opposition from pharmaceutical companies, who argue it could harm innovation and reduce investment, while the government and Trump claim it will bring significant savings and fairer pricing for American patients.
488 Articles
488 Articles
'All hat and no cattle': Democrats call Trump's bluff on drug price Executive Order
If U.S. President Donald Trump actually wants to curb out-of-control prescription drug prices, he'll throw his support behind legislative efforts instead of trying to do so unilaterally—an approach that's unlikely to survive legal challenges. That was the message that Sen. Bernie Sanders (I-Vt.) and congressional Democrats sent to the White House after Trump signed an executive order Monday aimed at pushing "pharmaceutical manufacturers to bring…
Pennsylvania Capital-Star
Trump signs order aiming to lower U.S. drug costs to match prices abroad
A pharmacy manager retrieves a bottle of antibiotics. (Photo by Joe Raedle/Getty Images)WASHINGTON — President Donald Trump signed an executive order Monday aimed at lowering drug prices by pressuring pharmaceutical companies to align their U.S. pricing models with those in similarly wealthy countries. “We’ll slash the cost of prescription drugs and will bring fairness to America,” Trump said at a morning White House event. “We’re all gonna pay …
Coverage Details
Bias Distribution
- 51% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
